Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ACE2 inhib
Welcome,
Profile
Billing
Logout
19 Companies
13 Products
13 Products
9 Diseases
27 Trials
1708 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
REGEN-COV
(casirivimab/imdevimab) / Regeneron, Roche
pruxelutamide
(GT0918) / Kintor Pharma
Regkirona
(regdanvimab) / Celltrion
ensovibep
(MP0420) / AGC Biologics, Molecular Partners, Novartis
cysteamine-pantetheine disulfide
(TTI-0102) / Thiogenesis Therap
B38-CAP
/ Kafrelsheikh University
ACE2 CAR-NK cells
/ Chongqing Sidemu Biotechnology Technology
CG-SpikeDown
/ Caregen
GL1001
/ Ore Holdings
HBM9022
/ Utrecht University, Erasmus MC, Harbour BioMed, AbbVie
IMM-BCP-01
/ Immunome
LY-CovMab
/ Luye Group
NKG2D-ACE2 CAR-NK cells
/ Chongqing Sidemu Biotechnology Technology
rimteravimab
(XVR011) / ExeVir Bio
